Col3.6-HSD2 transgenic mice: A glucocorticoid loss-of-function model spanning early and late osteoblast differentiation

Bone

Volumn 47, Issue 3, 2010, Pages 573-582

  Yang, Maobin ^a   Trettel, Lorin B ^a   Adams, Douglas J ^a   Harrison, John R ^a   Canalis, Ernesto ^b   Kream, Barbara E ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

11 beta hydroxysteroid dehydrogenase type 2; Glucocorticoids; Osteoblasts; Osteoclasts; Transgenic mice

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; COLONY STIMULATING FACTOR 1; CORTICOSTERONE; INTEGRIN; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; SIALOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE MINERALIZATION; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEVELOPMENTAL STAGE; FEMALE; FEMUR; HORMONE ACTION; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; STROMA CELL; TIBIA; TRABECULAR BONE; TRANSGENIC MOUSE; VERTEBRA;

ANIMALS; BONE AND BONES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; GLUCOCORTICOIDS; HYDROXYSTEROID DEHYDROGENASES; MALE; MICE; MICE, TRANSGENIC; MICROARRAY ANALYSIS; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION;

EID: 77955844496     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.06.002     Document Type: Article

References (59)

1. Canalis E. Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2003, 15:454-457.
2. Weinstein R.S., Jilka R.L., Parfitt A.M., Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998, 102:274-282.
3. Bellows C.G., Aubin J.E., Heersche J.N. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 1987, 121:1985-1992.
4. Rickard D.J., Sullivan T.A., Shenker B.J., Leboy P.S., Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994, 161:218-228.
5. Sher L.B., Woitge H.W., Adams D.J., Gronowicz G.A., Krozowski Z., Harrison J.R., Kream B.E. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 2004, 145:922-929.
6. Sher L.B., Harrison J.R., Adams D.J., Kream B.E. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif Tissue Int 2006, 79:118-125.
7. DeVack C., Lupp B., Nichols M., Kowenz-Leutz E., Schmid W., Schutz G. Characterization of the nuclear proteins binding the CACCC element of a glucocorticoid-responsive enhancer in the tyrosine aminotransferase gene. Eur J Biochem 1993, 211:459-465.
8. Drouin J., Sun Y.L., Chamberland M., Gauthier Y., De Lean A., Nemer M., Schmidt T.J. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 1993, 12:145-156.
9. Stocklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996, 383:726-728.
10. Grosset C., Jazwiec B., Taupin J.L., Liu H., Richard S., Mahon F.X., Reiffers J., Moreau J.F., Ripoche J. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 1995, 86:3763-3770.
11. Stewart P.M., Krozowski Z.S. 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm 1999, 57:249-324.
12. Woitge H., Harrison J., Ivkosic A., Krozowski Z., Kream B. Cloning and in vitro characterization of alpha 1(I)-collagen 11 beta-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoids. Endocrinology 2001, 142:1341-1348.
13. Dacic S., Kalajzic I., Visnjic D., Lichtler A.C., Rowe D.W. Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res 2001, 16:1228-1236.
14. Kalajzic I., Kalajzic Z., Kaliterna M., Gronowicz G., Clark S.H., Lichtler A.C., Rowe D. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 2002, 17:15-25.
15. Liu F., Lee S.K., Adams D.J., Gronowicz G.A., Kream B.E. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment. Bone 2007, 40:1135-1143.
16. Gazzerro E., Pereira R.C., Jorgetti V., Olson S., Economides A.N., Canalis E. Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 2005, 146:655-665.
17. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
18. McLeod M.J. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 1980, 22:299-301.
19. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
20. Lee S.K., Lorenzo J.A. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 1999, 140:3552-3561.
21. Yang M., Kream B.E. Calcitonin induces expression of the inducible cAMP early repressor in osteoclasts. Endocr 2008.
22. Eyre D.R. Bone biomarkers as tools in osteoporosis management. Spine 1997, 22:17S-24S.
23. Kalajzic I., Staal A., Yang W.P., Wu Y., Johnson S.E., Feyen J.H., Krueger W., Maye P., Yu F., Zhao Y., Kuo L., Gupta R.R., Achenie L.E., Wang H.W., Shin D.G., Rowe D.W. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem 2005, 280:24618-24626.
24. Mocetti P., Silvestrini G., Ballanti P., Patacchioli F.R., Di Grezia R., Angelucci L., Bonucci E. Bcl-2 and Bax expression in cartilage and bone cells after high-dose corticosterone treatment in rats. Tissue Cell 2001, 33:1-7.
25. Silvestrini G., Ballanti P., Patacchioli F.R., Mocetti P., Di Grezia R., Wedard B.M., Angelucci L., Bonucci E. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 2000, 26:33-42.
26. Zhou H., Mak W., Kalak R., Street J., Fong-Yee C., Zheng Y., Dunstan C.R., Seibel M.J. Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice. Development 2009, 136:427-436.
27. Kim J., Temple K.A., Jones S.A., Meredith K.N., Basko J.L., Brady M.J. Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels. J Biol Chem 2007, 282:11038-11046.
28. Balachandran A., Guan H., Sellan M., van Uum S., Yang K. Insulin and dexamethasone dynamically regulate adipocyte 11{beta}-hydroxysteroid dehydrogenase type 1. Endocrinology 2008.
29. Kershaw E.E., Morton N.M., Dhillon H., Ramage L., Seckl J.R., Flier J.S. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005, 54:1023-1031.
30. Stromstedt P.E., Poellinger L., Gustafsson J.A., Carlstedt-Duke J. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol Cell Biol 1991, 11:3379-3383.
31. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., Dacquin R., Mee P.J., McKee M.D., Jung D.Y., Zhang Z., Kim J.K., Mauvais-Jarvis F., Ducy P., Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
32. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008, 105:5266-5270.
33. Boban I., Jacquin C., Prior K., Barisic-Dujmovic T., Maye P., Clark S.H., Aguila H.L. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells. Bone 2006, 39:1302-1312.
34. Khosla S. Re: "The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells" by Boban et al. (Bone 39:1302-1312, 2006). Bone 2007, 40:1671-1672. author reply 1673-4.
35. Kim H.J., Zhao H., Kitaura H., Bhattacharyya S., Brewer J.A., Muglia L.J., Ross F.P., Teitelbaum S.L. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 2006, 116:2152-2160.
36. O'Brien C.A., Jia D., Plotkin L.I., Bellido T., Powers C.C., Stewart S.A., Manolagas S.C., Weinstein R.S. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 2004, 145:1835-1841.
37. Liu F., Woitge H.W., Braut A., Kronenberg M.S., Lichtler A.C., Mina M., Kream B.E. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol 2004, 48:645-653.
38. Mazziotti G., Angeli A., Bilezikian J.P., Canalis E., Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 2006, 17:144-149.
39. Canalis E., Mazziotti G., Giustina A., Bilezikian J.P. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007, 18:1319-1328.
40. Munck A. Glucocorticoid receptors and physiology: a personal history. Steroids 2005, 70:335-344.
41. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000, 21:55-89.
42. Weinstein R.S., Wan C., Liu Q., Wang Y., Almeida M., O'Brien C.A., Thostenson J., Roberson P.K., Boskey A.L., Clemens T.L., Manolagas S.C. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 2010, 9:147-161.
43. Fu M., Wang C., Li Z., Sakamaki T., Pestell R.G. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004, 145:5439-5447.
44. Xiong Y., Connolly T., Futcher B., Beach D. Human D-type cyclin. Cell 1991, 65:691-699.
45. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389:251-260.
46. Probst A.V., Dunleavy E., Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 2009, 10:192-206.
47. Turner B.M. Histone H4, the cell cycle and a question of integrity. Bioessays 1995, 17:1013-1015.
48. Kimura H., Cook P.R. Kinetics of core histones in living human cells: little exchange of H3 and H4 and some rapid exchange of H2B. J Cell Biol 2001, 153:1341-1353.
49. Jackson V., Chalkley R. A reevaluation of new histone deposition on replicating chromatin. J Biol Chem 1981, 256:5095-5103.
50. Cheng S.L., Lai C.F., Fausto A., Chellaiah M., Feng X., McHugh K.P., Teitelbaum S.L., Civitelli R., Hruska K.A., Ross F.P., Avioli L.V. Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells. J Cell Biochem 2000, 77:265-276.
51. Tani-Ishii N., Tsunoda A., Umemoto T. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro. J Periodontal Res 1997, 32:480-486.
52. Reinholt F.P., Hultenby K., Oldberg A., Heinegard D. Osteopontin--a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A 1990, 87:4473-4475.
53. Mohiti J., Caswell A.M., Walker J.H. Calcium-induced relocation of annexins IV and V in the human osteosarcoma cell line MG-63. Mol Membr Biol 1995, 12:321-329.
54. Giner R.M., Mancini L., Kamal A.M., Perretti M. Uneven modulation of the annexin 1 system in osteoblast-like cells by dexamethasone. Biochem Biophys Res Commun 2007, 354:414-419.
55. Kirsch T., Harrison G., Golub E.E., Nah H.D. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem 2000, 275:35577-35583.
56. Damazo A.S., Moradi-Bidhendi N., Oliani S.M., Flower R.J. Role of annexin 1 gene expression in mouse craniofacial bone development. Birth Defects Res A Clin Mol Teratol 2007, 79:524-532.
57. Shibanuma M., Kuroki T., Nose K. Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. J Biol Chem 1992, 267:10219-10224.
58. Leung Y.F., Tam P.O., Lee W.S., Lam D.S., Yam H.F., Fan B.J., Tham C.C., Chua J.K., Pang C.P. The dual role of dexamethasone on anti-inflammation and outflow resistance demonstrated in cultured human trabecular meshwork cells. Mol Vis 2003, 9:425-439.
59. Sena K., Leven R.M., Mazhar K., Sumner D.R., Virdi A.S. Early gene response to low-intensity pulsed ultrasound in rat osteoblastic cells. Ultrasound Med Biol 2005, 31:703-708.